Immune responses during acute and chronic infection with hepatitis C virus.
about
Acute hepatitis C: prevention and treatmentToll-like receptors in pathophysiology of liver diseasesPotent Hepatitis C Virus NS5A Inhibitors Containing a Benzidine Core.Liposome-coupled peptides induce long-lived memory CD8 T cells without CD4 T cells.Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells.Characterization of antigenic variants of hepatitis C virus in immune evasion.Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.Natural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's.Apoptotic effects of a chimeric plant virus carrying a mimotope of the hepatitis C virus hypervariable region 1: role of caspases and endoplasmic reticulum-stress.Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis C.Ever closer to a prophylactic vaccine for HCV.HLA and infectious diseases.Toll-like receptors as targets in chronic liver diseases.Toll-like receptors as therapeutic targets in gastrointestinal diseases.Advances in hepatitis C virus vaccines, Part one: Advances in basic knowledge for hepatitis C virus vaccine design.Genomic variation-guided management in chronic hepatitis C.Toll-like receptors in hepatitis C infection: implications for pathogenesis and treatment.Role of toll-like receptors in liver transplantation.Progress in the development of vaccines for hepatitis C virus infection.Prediction and identification-based prediction of Chinese hepatitis C viral-specific cytotoxic T lymphocyte epitopes.Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection.Design and expression of fusion protein consists of HBsAg and Polyepitope of HCV as an HCV potential vaccine.Characteristics of chronic hepatitis C among intravenous drug users: a comparative analysisIdentification and retrospective validation of T-cell epitopes in the hepatitis C virus genotype 4 proteome: an accelerated approach toward epitope-driven vaccine development.Calpain activation by hepatitis C virus proteins inhibits the extrinsic apoptotic signaling pathway.Acute hepatitis C in Brazil: results of a national survey.Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.The -> and -> in the Gene Are Associated With Viral Load and Liver Enzyme Levels in Patients With Chronic Viral Liver Diseases
P2860
Q22305934-3665C8A8-71F6-43AD-8BBB-6BA570678F0FQ28070077-00175E8E-6FBF-4D07-A3E0-38ED179FF8C2Q33636103-CBB719DA-8E5B-4369-ABD8-D8D749B50317Q33802868-21356605-BA7D-4881-8FB7-8DB299DB7130Q33992829-0CCEB5E2-3162-4EF8-A60A-D624D176C3C3Q34146011-D9911D7C-3328-4116-BE65-3B11BE664705Q35170607-1934E5D0-281D-44FF-AC2B-BE254A41E438Q35193959-E6E65E91-7F0A-4E83-A6D8-FC301B0B5B87Q36067577-3D0CF670-18E4-4799-B8DC-5957A5949E4AQ36074656-FBC0D45B-94B0-4530-A3DB-9FD8AB61D7B8Q36535789-B8D09F34-A90C-4D86-8AC1-B2680E1D3855Q37089122-8B983823-115C-49AF-B962-BAA420C1D3B1Q37444410-39529A4D-D1A8-41E9-8C69-1A1DF0D6E1DCQ37469924-103343D8-B1C4-4152-B34F-7861E5D9D3CEQ37690323-6AB995F9-0C9C-4F60-B7B0-7DD69381393DQ37948856-66EB46F7-CBFB-4889-9B34-299A9FA9E727Q38038693-32AEA37E-A74C-4C6A-A6B4-4DCE1077AD41Q38083773-9C036D4F-42A3-4981-A174-9D54886A575BQ38163493-799F5248-4E28-4F00-9B18-7C6C061E5914Q38635596-9474EAC5-230E-4106-BBAB-E97A819236DEQ39745734-C31DA21D-9DC8-4196-B0FF-E0951744FDE7Q40588780-CF14CDDA-3341-4370-8015-FF0586006095Q40866024-6C595EAC-4392-4967-B6CE-6E29DA1C01CAQ41008122-E121E0E9-C838-40A6-9171-50320DAEACE3Q41648212-99F764F9-D74C-4CDF-8D50-08256F96E598Q42990432-130BC64E-8776-47E9-A8D2-B3126BE19F30Q45176997-5E02A626-5217-4248-8572-7BDEE82CA944Q45366419-BBCAE093-A277-408C-B091-83E712325AEBQ58764816-AF3C5F18-356C-42D8-A34A-50C045BF34E0
P2860
Immune responses during acute and chronic infection with hepatitis C virus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immune responses during acute and chronic infection with hepatitis C virus.
@en
Immune responses during acute and chronic infection with hepatitis C virus.
@nl
type
label
Immune responses during acute and chronic infection with hepatitis C virus.
@en
Immune responses during acute and chronic infection with hepatitis C virus.
@nl
prefLabel
Immune responses during acute and chronic infection with hepatitis C virus.
@en
Immune responses during acute and chronic infection with hepatitis C virus.
@nl
P2860
P1433
P1476
Immune responses during acute and chronic infection with hepatitis C virus.
@en
P2093
Margaret James Koziel
Shigeaki Ishii
P2860
P304
P356
10.1016/J.CLIM.2008.03.525
P577
2008-06-02T00:00:00Z